https://www.selleckchem.com/pr....oducts/zotatifin.htm
Political decision on benefit package should be informed by evidence on cost effectiveness, equity dimension and health system capacity to deliver equitable services. Low- and middle-income countries need to strengthen HTA capacity to generate evidence and inform policies. © 2020 The Author(s); Published by Kerman University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http//creativecommons.org/ licenses/by/4., which permits unrestricted use, distributio
Like
Comment
Share
